nanovibronix.com (NAOV) - Aggregate Business Assets

NAOV (NanoVibronix Inc.) - company brandmark

NanoVibronix, Inc. (NAOV) delegates electronics assembly and testing to third-party partners to optimize supply chains. Currently, cash flow from device sales remains weak, and a lack of liquidity is constraining business growth. This price chart on GURU.Markets shows total assets at 44.19, while the company implements eco-friendly packaging design and responsible management principles.

NAOV (NanoVibronix, Inc.) Company Total Assets history from 07/04/2022 to 12/12/2025

Financial and market metric breakdowns for NanoVibronix, Inc. (NAOV)

- share price and consensus valuation forecast:
Price Chart NanoVibronix Inc.|NAOV - Consensus Target
- market capitalization indicators:
Market Value NanoVibronix, Inc.|NAOV - Enterprise Value
- balance sheet net asset value indicators:
Accounting Value of a Share NanoVibronix|NAOV - Book Capitalization|Market-to-Book Ratio nanovibronix.com|NAOV - Aggregate Company Assets
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio NanoVibronix, Inc.|NAOV - Long-Term Debt to Capital|Short-Term Debt to Capital nanovibronix.com|NAOV - Company Debts|Debts to Book Capitalization Ratio NanoVibronix, Inc.|NAOV - Company Long-Term Debts|Short-Term Debt NanoVibronix|Quick Ratio nanovibronix.com
- net income and valuation multiples indicators:
NAOV - Net Income
Basic company analysis:NanoVibronix Inc. NAOV
Manufactured products of NanoVibronix, Inc.

For NanoVibronix, Inc. (NAOV), the development of US-based production capacities for certified acoustic therapy systems correlates directly with the company's resource dynamics, where total asset size is inversely restored via the ROA metric to determine the market consensus on asset value. Investors should interpret this curve as a business scaling indicator, where balance sheet expansion without a corresponding increase in efficiency signals a risk of capital illiquidity.

Direct competitors

DXCM (dexcom.com) - Aggregate Company Assets|Cumulative Company Assets PEN|NOVT (Novanta Inc) - Aggregate Business Assets|Company Total Assets HAE|INSP (Inspire Medical Systems Inc) - Aggregate Asset Value|Company Total Assets PRCT (PROCEPT BioRobotics)|conmed.com (CNMD) - Company Assets|PLSE - Aggregate Company Assets|Aggregate Asset Value INMD (InMode Ltd)|PMI: Company Total Assets|Surmodics Inc. (SRDX) - Company Total Assets|Aggregate Company Assets Senseonics Holdings Inc|neuropace.com - Total Asset Value of Company|Company Total Assets TCMD|SNWV - Company Assets|Outset - Cumulative Company Assets|Company Total Assets SmartVest ELMD|LNSR: Cumulative Company Assets|avitamedical.com - Aggregate Business Assets|PROF: Company Total Assets|BDMD - Company Total Asset Base|EDAP (EDAP TMS SA) - Company Total Assets|Cumulative Company Assets Bovie Medical (APYX)|Cumulative Company Assets ICCM (IceCure Medical Ltd)|LUNG (pulmonx.com) - Aggregate Asset Value|Aggregate Company Assets TELA Bio TELA|CTSO - Cumulative Company Assets|Sensus Healthcare Corp - Company Total Assets|Company Assets Zynex Corp|ECOR: Company Total Assets|Total Business Assets RBOT|IINN (Inspira Technologies Oxy B.H.N. Ltd.) - Company Total Assets|SeaStar Medical Holding Corporation (ICU) - Company Total Asset Base|Company Total Assets IRIX|Cumulative Company Assets ibs.inc INBS|Company Total Assets XAIR (Beyond Air)|Company Total Assets profusa.com PFSA|SSKN - Aggregate Company Assets|GCTK: Aggregate Company Assets|VERO (Venus Concept Corp) - Cumulative Company Assets|Nuwellis Corp - Aggregate Asset Value|AEMD (Aethlon Medical) - Company Total Assets|Company Assets TransEnterix ASXC|Aggregate Company Assets Avinger (AVGR)|BioSig Technologies (BSGM) - Company Balance Sheet Assets|Cutera, Inc - Cumulative Company Assets|Company Total Assets Know Labs Corporation KNW|Inari Medical, Inc. - Company Total Assets|Company Total Asset Base nevro.com NVRO|reshapelifesciences.com (RSLS) - Aggregate Company Assets|Total Asset Value of Company SILK (Silk Road Medical, Inc.)